This Gates-backed, MIT-based biotech company solves a key vaccination problem

{ object.primary_image.title }}

Immunization (including the COVID-19 vaccine) often requires more than one shot. What if the first shot included time-release particles that automatically gave you the second shot at the same time? One of the logistical challenges with COVID-19 vaccines is the fact that many of the vaccines in development—including from Pfizer and Moderna—require two doses. If it’s hard to deliver a vaccine to nearly the entire global population once, it’s even harder to do it twice. The same problems exist for many childhood vaccines, and that’s one reason that children in the developing world are often undervaccinated. Read Full Story

More

Inside one of the new, quick-build factories making the Moderna vaccine

{ object.primary_image.title }}

The race to produce as much of the new vaccine as possible goes through these factories, which were spun up much faster than usual by building the shells before the vaccine production process was finalized. In a mountain valley in the Swiss Alps, new production lines are spinning up to produce the key ingredient for hundreds of millions of doses of Moderna’s COVID-19 vaccine, which the Food and Drug Administration approved for emergency use in the U.S. on December 18. This type of factory would normally take years to build. But Lonza, the manufacturer, used a new approach that made it possible to finish the work in months. Read Full Story

More

How to build an equitable vaccine passport that respects people’s privacy

{ object.primary_image.title }}

Rebuilding trust in our institutions starts with empowering individuals to control their own data. One of President Joe Biden’s executive orders aimed at curbing the pandemic asks government agencies to “assess the feasibility” of linking coronavirus vaccine certificates with other vaccination documents and producing digital versions of them. A vaccine passport, an official document that shows your vaccination status, may soon be required to work or travel. Airlines, industry groups, nonprofits, and technology companies are building a version of this idea that you can display on your mobile phone as an app or part of your digital wallet. Read Full Story

More

Sorry, the COVID-19 vaccine won’t make life go back to normal right away

{ object.primary_image.title }}

If you were hoping that the new COVID-19 vaccines could make it possible to stop wearing masks and social distancing, think again. Pfizer’s new COVID-19 vaccine might get FDA emergency use authorization in a few weeks, and a small group of Americans might begin getting shots in December. Moderna’s vaccine might quickly follow. But even for those who can get vaccinated soon—potentially 20 million people in the U.S., out of a population of more than 320 million—life won’t be able to go back to normal yet. Read Full Story

More

When can kids get the COVID-19 vaccine? A pediatrician answers 5 key questions

{ object.primary_image.title }}

Both Moderna and Pfizer are testing the vaccine in children now. A big question among parents and teachers as more schools reopen is when their kids will be vaccinated against COVID-19. Some have wondered whether the vaccine is even necessary for children. Dr. James Wood , a pediatrician and assistant professor of pediatric infectious diseases, explains what doctors know today about the risk children face of getting and spreading the coronavirus and when vaccines might be available. Read Full Story

More

Subscribe to our newsletter

Join our newsletter and never miss out trending marketing news.

HitcountVariables(pk=17831, ajax_url='/api/hit/ajax/', hits='3')